Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial

Lancet

Volumn 355, Issue 9203, 2000, Pages 517-522

  Vermeulen, E G J ^a   Stehouwer, C D A ^b   Twisk, J W R ^c   Van Den Berg, M ^a   De Jong, S C ^a   Mackaay, A J C ^a   Van Campen, C M C ^b   Visser, F C ^b   Jakobs, C A J M ^a   Bulterijs, E J ^a   Rauwerda, J A ^a  

^a Univ Hosp Inst C   (Netherlands)

^b Univ Hosp Inst Cardiovasc R   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AMINO ACID BLOOD LEVEL; ANKLE PRESSURE; ARTERY BLOOD FLOW; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; FEMORAL ARTERY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIBLING;

EID: 0034639639     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)07391-2     Document Type: Article

References (33)

1. McCully K.S., Ragsdale B.D. Production of arteriosclerosis by homocysteinaemia. Am J Pathol. 61:1970;1-11.
2. Wilcken D.E., Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest. 57:1976;1079-1082.
3. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 274:1995;1049-1057.
4. Graham I.M., Daly L.E., Refsum H.M.et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA. 277:1997;1775-1781.
5. Stampfer M.J., Malinow M.R., Willett W.C.et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 268:1992;877-881.
6. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 337:1997;230-236.
7. Stehouwer C.D., Gall M.A., Hougaard P., Jakobs C., Parving H.H. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney Int. 55:1999;308-314.
8. Verhoef P., Hennekens C.H., Malinow M.R., Kok F.J., Willett W.C., Stampfer M.J. A prospective study of plasma homocyst(e)ine and risk of ischaemic stroke. Stroke. 25:1994;1924-1930.
9. Alfthan G., Pekkanen J., Jauhiainen M.et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 106:1994;9-19.
10. Evans R.W., Shaten B.J., Hempel J.D., Cutler J.A., Kuller L.H. Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial. Arterioscler Thromb Vasc Biol. 17:1997;1947-1953.
11. Folsom A.E., Nieto F.J., McGovern P.G.et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphism, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 98:1998;204-210.
12. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ. 316:1998;894-898.
13. 6 plus folic acid in young patients with arteriosclerosis and hyperhomocysteinaemia. J Vasc Surg. 20:1994;933-940.
14. van den Berg M., Stehouwer C.D., Bierdrager E., Rauwerda J.A. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. Arterioscler Thromb Vasc Biol. 16:1996;165-171.
15. de Jong S.C., Stehouwer C.D., Mackaay A.J.et al. High prevalence of hyperhomocysteinemia and asymptomatic vascular disease in siblings of young patients with vascular disease and hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 17:1997;2655-2662.
16. de Jong S.C., Stehouwer C.D.A., van den Berg M., Geurts T.W., Bouter L.M., Rauwerda J.A. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease: a prospective cohort study. J Intern Med. 246:1999;87-96.
17. Ubbink J.B., Hayward Vermaak W.J., Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 565:1991;441-446.
18. Bruce R.A., DeRouen T.A., Hossack K.F. Value of maximal exercise tests in risk assessment of primary coronary heart disease events in healthy men. Five years' experience of the Seattle heart watch study. Am J Cardiol. 46:1980;371-378.
19. van Campen C.M., Visser F.C., Visser C.A. The QRS score: a promising new exercise score for detecting coronary artery disease based on exercise-induced changes of Q-, R- and S-waves: a relationship with myocardial ischaemia. Eur Heart J. 17:1996;699-708.
20. Fowkes F.G. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol. 17:1988;248-254.
21. Fowkes F.G., Housley E., Macintyre C.C., Prescott R.J., Ruckley C.V. Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease. J Epidemiol Community Health. 42:1988;128-133.
22. Moneta G.L., Edwards J.M., Chitwood R.W.et al. Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. J Vasc Surg. 17:1993;152-157.
23. Strandness D.E. Jr. Noninvasive evaluation of arteriosclerosis: comparison of methods. Arteriosclerosis. 3:1983;103-116.
24. Mackaay A.J., Beks P.J., Dur A.H.et al. The distribution of peripheral vascular disease in a Dutch Caucasian population: comparison of type II diabetic and non-diabetic subjects. Eur J Vasc Endovasc Surg. 9:1995;170-175.
25. Williams M.A., Deacon D.F., Szendro G.et al. Duplex scanning in detection and grading of internal carotid artery stenosis: improved criteria. Nicolaides A.N., Salmasi M.A. Cardiovascular applications of doppler ultrasound. 1989;247-260 Churchill Livingstone, New York.
26. Aly S., Sommerville K., Adiseshiah M., Raphael M., Coleridge Smith P.D., Bishop C.C. Comparison of duplex imaging and arteriography in the evaluation of lower limb arteries. Br J Surg. 85:1998;1099-1102.
27. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 42:1986;121-130.
28. Twisk J.W. Different statistical models to analyze epidemiological observational longitudinal data: an example from the Amsterdam Growth and Health Study. Int J Sports Med. 18:1997;216-226.
29. Mudd S.H., Levy H.L., Skovby F. Disorders of transsulfuration. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic and molecular basis of inherited disease. 1995;1279-1327 McGraw-Hill, New York.
30. Peterson J.C., Spence J.D. Vitamins and progression of atherosclerosis in hyperhomocyst(e)inaemia. Lancet. 351:1998;263.
31. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 338:1998;1042-1050.
32. Verhaar M.C., Wever R.M., Kastelein J.J., van Dam T., Koomans H.A., Rabelink T.J. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolaemia. Circulation. 97:1998;237-241.
33. Refsum H., Ueland P.M., Nygard O., Vollset S.E. Homocysteine and cardiovascular disease. Annu Rev Med. 49:1998;31-62.